Prognostic Markers

Variation in serum alkaline DNase activity-a sensitive clinical test for therapeutic monitoring of cancer patients

HS Taper, B Dewez, V Allaeys, A Karaoglou, M Roberfroid

Serial CA15-3 levels in the follow-up of patients with breast cancer

MJ Kerin, DM O'Hanlon, C O'Boyle, T Boyle, H Grimes, D Maher, HF Given

Extracellular matrix profiles in bronchopulmonary carcinomas

F Galateau, S Peyrol, P Sommer, P Rousselot,JA Grimaud

Breast epithelial mucin levels in serum of breast cancer patients with a recombinant epitope assay

RL Ceriani,R Kiwan, J Leon, JA Peterson

Measurement of TPS complements CA15-3 in the follow-up of patients with breast carcinoma

DM O'Hanlon, MJ Kerin, C O'Boyle, T Boyle, D Maher, H. Grimes, HF Given

A clinical study on serum and tissue levels of tumor markers in uterine cervical carcinomas

A Ishikawa, T Nakano, A Terahara, S Morita

The expression of gp14o proto-trk as a prognosis marker of neuroblastoma

H Iwata, E Nakura, Y Ishiguro, T Ito, M Hamaguchi

Simultaneous quantitative analyses of erbB2 protein, EGFR, Cathepsin D and hormone receptors in breast cancer tissues

H Iwase, S Kobayashi, Y Itoh, T Kuzushima, H Iwata, A Masaoka

Epidermal growth factor receptor (EGFR) and HER-2/neu oncoproteins as prognostic markers for endometrial adenocarcinoma

M Khalifa, A Abdoh, R Mannel, S Haraway, J Walker, K-W Min

Abnormality of c-erbB-2 gene and its product in gastric cancer as a prognostic factor

Y Yonemura, I Ninomiya, H Fujita, I Miyazaki, Y Endou, T Sasaki